✨
AI Summary
- Sernova and Seraxis merge to form BetaNova, aiming for T1D functional cure.
- Combining Cell Pouch technology with stem cell-derived pancreatic islets.
- Focus on developing a cell therapy for Type 1 diabetes patients.
Guests on This Episode
JR
Jonathan Rigby
researcher · 2 podcast appearances
WR
Will Rust
1 podcast appearance